Betterchem
Health     Drug Information     DMFs     Portal     21CFR     Search     Site Map

 

[search the news]  
 

Health and Pharmaceutical News Archive

 
                                                                   

 
Search our news archive and pharma companies…

Today's News | Note: News feeds may no longer be available for the articles on this page.

Chugai Says It's Cooperating in Japan Insider Trading Probe 6:21 AM 11/28/2009
Bloomberg
Chugai Pharmaceutical Co is majority-owned by Roche Holding AG. It's alleged that trades were made after a Chugai employee leaked that Roche planned to make a tender offer for the drugmaker. ...

FDA denies approval for Theravance's pneumonia drug 1:08 PM 11/27/2009
Reuters
Theravance Inc said the US FDA did not approve its drug Telavancin for treatment of nosocomial pneumonia asking for additional data which the company has on hand. ...

Baxter hopes to build US cell-based vaccine manufacturing plant 7:16 AM 11/26/2009
Chicago Tribune
Baxter expresses interest in vaccine production in the US. Democrat control of the US government and increased subsidies are making the business more lucrative. ...

Study Suggests Source of Post-Menopausal Hot Flashes 6:26 AM 11/26/2009
U.S. News & World Report
RANK receptor and the RANKL protein that binds to it turn up the heat to cause fever during infections. They are involved in osteoporosis and may also cause hot flashes that post-menopausal women experience. ...

Incyte's cancer drug deal with Novartis could be worth $1bn 5:44 AM 11/26/2009
Pharmafocus
Novartis paid Incyte Corporation for the rights to the Janus kinase (JAK) inhibitor INCB18424 in phase III to treat myelofibrosis and an early-stage mesenchymal-epithelial transition factor kinase (cMET) inhibitor INCB28060. ...

Novartis will end collaboration with Idera 10:53 AM 11/25/2009
Boston Globe
Novartis AG will terminate its research collaboration agreement with Idera Pharmaceuticals Inc in February when Idera will regain full rights to IMO-2134. Merck & Co has extended its research collaboration with Idera for a fourth year.

Roche seeks broader EU breast cancer label for drug 5:02 AM 11/25/2009
Reuters
Roche Holding filed for European approval to extend use of its Avastin drug to patients with metastatic breast cancer in combination with Xeloda. ...

 

 

Lonza says to make blood cancer drug for Micromet 4:51 AM 11/25/2009
Reuters
Lonza Group agreed with US biotech firm Micromet to manufacture blinatumomab used to treat various hematologic cancers. ...

Vaccine Makers Struggle to Speed Output 4:33 AM 11/25/2009
Wall Street Journal
Novartis's new plant took more than three years to build and fine-tune the technology. Equipment and processes must be validated before it can start mass producing vaccines in the US. ...

Shire asks EU for Gaucher drug approval 6:25 AM 11/24/2009
Reuters
Genzyme was forced to cease production of Cerezyme when its manufacturing site became infected with a virus. Shire asked the EU to allow people to take its new Gaucher disease drug as supplies of Cerezyme run out. ...

Norway's Clavis signs $380 mln cancer drug deal 5:02 AM 11/24/2009
Reuters
Clavis Pharma signed a cancer drug development deal worth around $380 million with US-based Clovis Oncology for the development and commercialization of pancreatic cancer drug CP-4126. ...

Biotech bills give drugmakers too many years of exclusivity? 4:32 AM 11/24/2009
Boston Globe
Without innovation there wouldn't be drugs priced beyond the reach of some patients or upward pressure on health care costs. ...

Consumer drug ads drive up health costs 6:21 PM 11/23/2009
Reuters
Payers and policymakers should be concerned about direct-to-consumer advertising for publicly funded reimbursement programs such as Medicare and Medicaid because drugmakers appear to build the cost of the ads into their prices. ...

Vioxx risks could have been detected earlier: study 3:59 PM 11/23/2009
Reuters
Heart risks from Merck & Co's painkiller Vioxx could have been detected more than three years before the company withdrew the drug from the market. ...

Pfizer Units' Damages for Menopause Drugs Exceed $165 Million 2:59 PM 11/23/2009
Bloomberg
Two Pfizer units have to pay more than $165 million in punitive damages to women who developed cancer after taking menopause drugs. ...

<- Day Earlier | Today's News


 

FindingHealthOnline | Drug Thesaurus | Brand Names | Generic Names | News Digests | For Industry

You may search any of the key words from this page using the search window at the top.

© 2012 Betterchem.com